Mainz Biomed N.V. (QUCY) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

Mainz Biomed N.V. (QUCY) operates in the Healthcare sector, specifically the Medical - Diagnostics & Research industry, with a market capitalization near $36.7M, listed on NASDAQ, employing roughly 26 people, carrying a beta of 0.43 to the broader market. Mainz Biomed NV is a molecular genetics cancer diagnostic company. Led by Guido Baechler, public since 2021-11-05.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for QUCY as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →